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ABSTRACT: Background. Microenvironmental cues play a major role in
head and neck cancer. Biodegradable scaffolds used for bone regenera-
tion might also act as stimulative cues for head and neck cancer. The
purpose of this study was to establish an experimental model for precise
and noninvasive evaluation of tumorigenic potential of microenvironmen-
tal cues in head and neck cancer.
Methods. Bioluminescence was chosen to image tumor formation. Early
neoplastic oral keratinocyte (DOK) cells were luciferase-transduced
(DOKLuc), then tested in nonobese diabetic severe combined immunode-
ficient IL2rgnull mice either orthotopically (tongue) or subcutaneously for
their potential as “screening sensors” for diverse microenvironmental
cues.
Results. Tumors formed after inoculation of DOKLuc were monitored eas-
ier by bioluminescence, and bioluminescence was more sensitive in
detecting differences between various microenvironmental cues when
compared to manual measurements. Development of tumors from
DOKLuc grown on scaffolds was also successfully monitored noninva-
sively by bioluminescence.
Conclusion. The model presented here is a noninvasive and sensitive
model for monitoring the impact of various microenvironmental cues on
head and neck cancer in vivo. VC 2015 The Authors Head & Neck Pub-
lished by Wiley Periodicals, Inc. Head Neck 00: 000–000, 2015
KEY WORDS: cancer, microenvironment, bioluminescence, tissue
engineering, scaffold
INTRODUCTION
Recent evidence implicates environmental cues as key factors
in cancer progression.1 Among the important determinants is
the surrounding stroma, including fibroblasts, endothelial
cells, infiltrating immune cells, and extracellular matrix com-
ponents.2,3 The scaffolds used in tissue engineering as provi-
sional matrices for cell proliferation and extracellular matrix
deposition can also act as microenvironmental cues. The sur-
rounding tissues might react toward these by foreign body
reactions or even tumor formation,4 and long-term subcutane-
ous implants of nonabsorbable or slowly degrading materials
were shown to be tumorigenic.5,6 Thus, there is a great con-
cern that certain biomaterials may be potential initiators of
malignancies, and the size and surface roughness of certain
biomaterials were already suggested to influence tumor for-
mation.7 To date, at the regulatory level, the basic approach
for biomaterials’ safety is defined in the International Organi-
zation for Standardization 10993.8,9 These tests start with an
initial safety evaluation targeting leachable for cytotoxicity.
Genotoxicity and evaluation of mRNA levels of proto-
oncogenes and tumor suppressor genes10 from mammalian or
bacterial cells exposed to the biomaterials has also been used
as methods for safety check.11 Current carcinogenicity tests
determine the tumorigenic potential of materials and/or their
extracts from either single or multiple exposures or contacts
over a period of the major portion of the life span of the test
animal or transgenic mice.12 Long-term, conventional 2-year
rodent bioassays are often not feasible, with questionable
relevance also because of limitations associated with species
extrapolation.13,14 Finding a relevant animal model for every
kind of human cancer is impractical, but preclinical animal
xenograft tumor models, particularly heterotopic (subcutane-
ous), have proven useful especially in identifying cytotoxic
agents.15–18 On the other hand, although more technically
demanding, the orthotopic xenograft models simulate the
same local microenvironment and thus offer the advantage of
less complicated translation to the clinical setting.19
Scaffolds used for bone regeneration in the oral and
maxillofacial area might come in contact with the oral
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epithelium. Because over 90% of head and neck cancers
are, as most of the human malignancies, of epithelial ori-
gin,20,21 there is a need to study the potentially carcino-
genic effect of degradable bioengineered scaffolds on oral
epithelial cells. To study oral and head and neck carcino-
genesis, both orthotopic and heterotopic (subcutaneous)
models were previously developed by use of malignant
cells derived from established oral or head and neck can-
cer.22 In this study, we chose to develop a xenotransplan-
tation model by use of an early neoplastic oral
keratinocyte (DOK) cell line derived from early neoplas-
tic oral mucosa.23 These cells were found to be partly
transformed but nontumorigenic in nude mice, and were
described as having potential as “screening recipients” for
carcinogens in vitro.23
Different in vivo optical imaging modalities have been
tested in various tumor models.24–26 However, there is a
need for a noninvasive head and neck cancer model with
the ability to detect possible tumorigenic effects of vari-
ous microenvironmental cues, including implanted scaf-
folds. Bioluminescent imaging is a well-established
method in preclinical investigation of the complexity of
cancers27–29 including head and neck cancer,30,31 but for
a screening of the potential to fully transform and gener-
ate malignant tumors from the early neoplastic cells, the
application of bioluminescence would offer a novel non-
invasive approach. In carcinogenicity testing of biomateri-
als, controls of a comparable form and shape should be
included. However, in the presented system, the use of
appropriate controls is not necessary because the inclusion
of a positive environment with the use of carcinoma-
associated fibroblasts (CAFs) has been developed. The
noninvasive in vivo visualization for several weeks also
provides additional unique advantages over the aforemen-
tioned established carcinogenicity testing systems.
To achieve real-time bioluminescence in this study,
DOK cells were first transduced to contain the firefly
luciferase. They were then tested in vivo in NSG mice
for their potential as “screening sensors” for diverse
microenvironmental cues, such as various types of head
and neck CAFs and copolymer scaffolds intended for tis-
sue engineering. The biodegradable poly L-lactide-co-E-
caprolactone (poly[LLA-co-CL]), an aliphatic polyester
copolymer of L-lactic acid and E-caprolactone, has been
extensively studied at our laboratory as a scaffold for
bone regeneration proving its biocompatibility and osteo-
conductivity,8,32 and, hence, was chosen for developing
this model.
MATERIALS AND METHODS
Cell choice and maintenance
The DOK cell line was purchased from The European
Collection of Cell Cultures (Salisbury, Wiltshire, UK).23
They were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf
serum (FCS; Invitrogen, Waltham, MA), 20 lg/mL
L-glutamine, 5 lg/mL hydrocortisone (all from Sigma, St.
Louis, MO).
CAFs (n 5 3; CAF1, CAF15_13, and CAF15_23) were
isolated from histologically confirmed head and neck squa-
mous cell carcinoma, after receiving informed consent.
They were maintained in FAD medium: DMEM/Ham’s
F12 1:3 mixture, 1% L-glutamine, 0.4 lg/mL hydrocorti-
sone, 50 lg/mL ascorbic acid, 10 ng/mL epidermal growth
factor, 5 lg/mL insulin, and 20 lg/mL transferrin and lino-
leic acid (all from Sigma) with 10% FCS.
Luciferase transduction of early neoplastic oral
keratinocytes
Virus production. DOK wild type (DOKWT) cells were
transduced with a tTA, L192 construct (expressing lucif-
erase).33 Infectious retroviral vector particles were pro-
duced in Phoenix A cells (LGC Standards AB, Boras,
Sweden) cultured in DMEM, supplemented with 10%
FCS, 1% penicillin-streptomycin, and 1% glutamine.
When 70% to 80% was confluent, 8 lL of 50 mM chloro-
quine (Sigma) was added. Four micrograms of DNA con-
struct (tTA, L192) was mixed with 128 lL of 2M
calcium chloride (CaCl2) and sterile ddH2O to a total vol-
ume of 1 mL plus 1 mL of 23HEPES-buffered (Sigma)
and transferred onto each plate. After 12-hour incubation,
the medium was replaced by a fresh medium and by
DOK’s medium after 24 hours.
Infection and selection of luciferase-transduced early neoplastic
oral keratinocyte. The virus supernatant was collected, fil-
tered, and gene transfer enhanced with protamine sulfate
(5 lg/mL). DOKWT were seeded at 3 different seeding
densities (25 3 103; 50 3 103; and 100 3 103 cells/well)
in a 6-well plate and centrifuged at 1200 g for 90
minutes. The virus supernatant was replaced with the
DOK medium 24 hours postinfection. Successfully
infected DOK cells were selected by puromycin (1 lg/
mL; Sigma). To obtain a cell-clone with a stable, high
expression of luciferase, transduced DOK cells were
sorted using fluorescence-activated cell sorter (FACS
Aria SORP, BD Biosciences, San Jose, CA).
Selection of highly bioluminescent early neoplastic oral
keratinocyte luciferase-transduced cells
Approximately 1 3 106 cells of each group in 100 lL
DOK medium were transferred to 96-well plate with 1 well
containing 100 lL of DOK medium only for background
autofluorescence. Luciferin, (1.6 g/L of D-luciferin; Bio-
synth AG, Staad, Switzerland) was added 10 minutes
before imaging in the Time-Domain Small Molecular
Imager Optix MX3 (ART; GE Healthcare, Little Chalfont,
UK). Using the OptiView acquisition software (ART
Advanced Research Technologies, Quebec, Canada), the
region of interest was chosen and plates were scanned with
the scan step 1.0 mm and integration time 0.1 seconds.
Assessment of cell morphology and proliferation
Both cell types, DOKWT and early neoplastic oral kera-
tinocyte luciferase-transduced (DOKLuc), were cultured at
passages (45–48) and their morphology was compared
under a light microscope (Nikon TS100; Nikon, Tokyo,
Japan). The growth rate was analyzed using a colorimet-
ric assay based on methylthiazol tetrazolium (Sigma) and
measured at 570 nm using a microplate reader (BMG
LABTECH, GmbH, Ortenberg, Germany).
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Assessment of tumorigenicity in vivo
Both DOKWT and DOKLuc cells were cultured and
allowed to reach their log phase before they were trypsi-
nized and suspended in 50 lL of growth factor-reduced
matrigel (BD Biosciences). The cells were inoculated at 2
different densities, low (1 3 103) and high (1 3 105), at
2 different locations, the tongue and subcutaneously in
the back of 8 to 10 weeks old male nonobese diabetic
severe combined immunodeficient IL2rgnull mice (NSG)
(University of Bergen - originally a generous gift from
Prof. Leonard D. Shultz, Jackson Laboratories, Bar Har-
bor, ME; n 5 24, 6 mice for each group). Weekly for 6
weeks, tumor volumes for both cell types were manually
assessed by digital caliper, using the formula [length 3
(width2)/2]. In the group inoculated with DOKLuc, tumor
development was also measured weekly by biolumines-
cence. We euthanized the mice after 45 days and har-
vested tissues for histology.
Orthotopic tongue xenograft mouse model for early
neoplastic oral keratinocyte 1 carcinoma-associated
fibroblast co-inoculations
To create a positive tumor formation control, 1 3 103
DOKWT were suspended with 1 3 105 CAFs (CAF1) in
50 lL matrigel and inoculated in the tongue of NSG mice
(n 5 12; 6 mice for each group). Tumors were measured
manually up to 45 days.
To assess the sensitivity of bioluminescence to differen-
tiate between tumors formed by different strains of CAFs,
DOKLuc in a density of 1 3 103 were co-inoculated in
combination with 1 3 105 of 2 different strains of CAFs
(CAF15_13 and CAF15_23) in the tongue. The total
number of animals was 24 with at least 6 for each group.
The development of the tumors in this group was fol-
lowed up manually and evaluated weekly by
bioluminescence.
Preparation of cell-seeded poly L-lactide-co-E-
caprolactone scaffolds for ectopic subcutaneous
scaffold xenograft
The copolymer poly(LLA-co-CL) was polymerized
from E-caprolactone (Sigma–Aldrich, Germany) and LLA
(Boehringer, Ingelheim, Germany) by ring-open-
polymerization, as previously described.32 The average
molecular weight of the purified copolymer was 100,000
and polydispersity index 1.3 determined by Size Exclu-
sion Chromatography (Polymer Laboratories, Shropshire,
UK). The copolymer was composed of 75 mol % LLA
and 25 mol % caprolactone, confirmed by 1H-NMR
(Bruker Avance 400, Billerica, MA). The porous scaffolds
were prepared by solvent casting particulate leaching32
and a disc-shaped scaffold (diameter approximately 6
mm, thickness approximately 1.3 mm) was formed with
>83% porosities. Porosities were calculated by a Micro-
CT (Sky Scan 1172 scanner, Kontich, Belgium) using 40
kV and 2.4 micron voxel and 3D analysis was carried
using the software CT-Analyzer version 1.13 (Bruker).
The scaffolds were pre-wet with DOK medium and left
for 2 to 3 hours before being then seeded with cells,
DOKLuc alone or DOKLuc 1 CAFs (CAF1). Three differ-
ent densities of DOK were used (1 3 103, 1 3 105, and
1 3 106); the density of CAFs was fixed to 1 3 105.
Plates were vortexed (Eppendorf, Hamburg, Germany)
and the cells were allowed to attach overnight before
scaffolds were xenotransplanted in 8 to 10-week-old NSG
mice.
The mice were anesthetized with Isoflurane (Isoba
VetTM; Schering Plough, Kenilworth, NJ) before 2 inci-
sions (1 cm) were made on their back. One incision was
FIGURE 1. (A) Bioluminescence of early neoplastic oral keratino-
cyte luciferase-transduced (DOKLuc) cells at a density of 50 3
103 early neoplastic oral keratinocyte wild type (DOKWT) trans-
duced 4 times, displaying the highest photons/mm2/sec, white
arrow. (B) Light microscopy showing that DOKWT and DOKLuc
exhibit the same typical morphology and pattern of growth in the
form of coherent islands. (C) Growth curves for both cell types,
showing no significant difference (p 5 .262) between the in vitro
growth potential of DOKWT and DOKLuc. [Color figure can be
viewed in the online issue, which is available at wileyonlineli-
brary.com.]
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made between the upper limbs and another between the
lower limbs, providing sufficient space for implantation
of scaffolds and to avoid bioluminescence bleeding. Two
scaffolds were implanted into each mouse, 1 scaffold
with DOKLuc alone and the other with DOKLuc 1 CAFs.
The different densities were distributed among all mice (n
5 6). Wounds were closed with Histoacryl tissue adhe-
sive (B. Braun Surgical AS, Melsungen, Germany). At 12
weeks, the animals were euthanized with CO2 overdose
and scaffolds processed for histology.
Optical bioluminescence imaging
Mice were depilated and scanned after intraperitoneal
delivery of 150 mg/kg of D-luciferin. Animals were main-
tained under 1% gas anesthesia during scanning. Images
were captured using In Vivo MS FX PRO (Carestream
Health, Rochester, NY) and analyzed using Carestream
MI SE version 5.0.6.20, 1 exposure of 90-second
duration.
Histology and immunohistochemistry
Samples were fixed in 4% paraformaldehyde before
embedding in paraffin. Sections of 3 to 4 lm were
stained with hematoxylin-eosin (Sigma). For p53 immu-
nostaining, paraffin sections were deparaffinized and
rehydrated. Epitope retrieval was performed by heating
the sections in citrate buffer pH 6.0 in a microwave.
Endogenous enzyme activity and unspecific binding were
blocked using peroxidase block (DAKO, Golstrup, Den-
mark) and 10% normal goat serum (DAKO) for 5 minutes
and 30 minutes, respectively, at room temperature. As
primary antibody, p53 with a monoclonal specific anti-
body (DO-7 clone, DAKO) 1:50 was incubated for 1 hour
at room temperature. For negative controls, samples were
treated with antibody diluents alone. The bound reaction
was visualized using 3, 30-diaminobenzidine tetra hydro-
chloride (DAB, DAKO). Double staining with vimentin
(DAKO) 1:1000 was carried out using a double stain kit
(Envision Gj2 double stain system; DAKO), in accord
with the manufacturer’s instructions. Tumor areas were
FIGURE 2. Graphs comparing the
growth rate (tumor volume) and
the total area of tumors formed
by either early neoplastic oral
keratinocyte wild type (DOKWT)or
early neoplastic oral keratinocyte
luciferase-transduced (DOKLuc)
inoculated at cell densities of 103
or 105 in the tongues (A and C),
and subcutaneously (B and D) of
NSG mice (*p < .05). Histological
sections with hematoxylin-eosin
stain showing 6 weeks after inoc-
ulation of the tongue (E, F, H, and
I) and skin (G and J). The tumors
retain the characteristics of squa-
mous cell carcinoma (original
magnification 325 and 3200).
Scale bar 1 mm5 325 and 200
lm 5 3200. [Color figure can
be viewed in the online issue,
which is available at wileyonline-
library.com.]
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calculated from areas of interest in hematoxylin-eosin
sections using Olympus DP Soft 5.0 software (Munster,
Germany).
Ethics statement
The ethical approval for patients with head and neck squa-
mous cell carcinoma samples was obtained from the Regional
Committees for Medical and Health Research Ethics (REK
NO. 2010/48) and lesions were collected following ethical
approval and written informed consent of the patients. All ani-
mal experiments were approved by the Norwegian Animal
Research Authority and conducted in strict accordance with
the European Convention for the Protection of Vertebrates
used for Scientific Purposes (FOTS no. 20134643/20123961).
All procedures were performed under isoflurane gas anesthe-
sia, and all efforts were made to minimize suffering.
Statistical analysis
Average values were analyzed by IBM SPSS Statistics
21.0 (SPSS, Chicago, IL) and the data expressed as mean
6 SEM. Paired t test or the independent Mann–Whitney
U tests were used to compare differences between the
tumors formed. Spearman’s correlation was used to corre-
late the manual tumor measurements and histological
measurements with corresponding bioluminescence sig-
nals. Differences were considered statistically significant
when p < .05.
RESULTS
Successful transduction of early neoplastic oral
keratinocyte with luciferase containing vector generated
a new cell line
The bioluminescence signal recorded for DOKLuc cells
cultured in vitro for 2 to 3 weeks posttransduction showed
that the seeding density of 50 3 103 displayed the highest
photons/mm2/sec (Figure 1A, white arrow). Cells derived
following this protocol were expanded and used for fur-
ther in vivo experiments. Light microscopy showed that
DOKWT and DOKLuc had typical epithelial morphology
and similar patterns of growth in the form of coherent
islands. No signs of epithelial-to-mesenchymal transition
could be observed in either (Figure 1B). The growth
curve was comparable for the 2 cell types (p 5 .262),
indicating that transduction with luciferase did not alter
the in vitro growth potential of these cells (Figure 1C).
The in vivo tumorigenic potential of DOK cells before
and after transduction with luciferase expressing gene was
evaluated after DOKWT and DOKLuc were inoculated in the
tongue and also subcutaneously in NSG mice at low (1 3
103) and high (1 3 105) density. At the high inoculation
density, visible tumors were detected with the same inci-
dence after 2 weeks, at both sites, for both DOKWT and
DOKLuc. At the low density, tumors formed only in the
tongue, and after 4 weeks, with the same incidence for
FIGURE 3. Bioluminescence (BLI) of mice for 5 weeks after inoculation with early neoplastic oral keratinocyte luciferase-transduced (DOKLuc) cells
(105 and 103 densities) in the tongue (A) and in the skin (B). Graphs depicting increasing total photon intensities from tongue inoculations (C) with
a lower overall photon count produced from 103 densities (**p < .01). (D) Total photon intensities of cells for 5 weeks after subcutaneous inocula-
tion (**p < .01). Data shown as means 6 SEM. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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DOKWT and DOKLuc. There was no statistical significance
between the volume of the tumors formed in both tongue
and subcutaneously by DOKWT and DOKLuc at all time-
points (Figures 2A and 2B). The histological area of the
tumors derived from DOKWT and DOKLuc at low density in
the tongue (Figure 2C) and at high density subcutaneously
(Figure 2D) did not show any statistical significant differ-
ence. The only statistical significant difference was found for
the tongue tumors formed at higher inoculation density by
DOKLuc than tumors formed by DOKWT (p < .05; Figure
2C). Tumor xenografts generated from DOKWT (Figures 2E–
2G) showed the same histological picture as DOKLuc xeno-
grafts (Figures 2H–2J), with epithelial islands of atypical epi-
thelial cells in the host stroma and keratin pearls.
Development of tumors formed after inoculation of early
neoplastic oral keratinocyte luciferase transduced cells
was easily monitored by bioluminescence
Luciferase activity increased with time after both
tongue and subcutaneous inoculations for both inoculation
densities (Figures 3A and 3B). The bioluminescence sig-
nal was significantly higher for the inoculations of
DOKLuc at higher inoculation density at both tongue and
subcutaneous locations (Figures 3C and 3D), at all time-
points, correlating well with the tumor growth curve as
assessed by the manual measurements.
Both early neoplastic oral keratinocyte wild type and
early neoplastic oral keratinocyte luciferase-transduced
were responsive to carcinoma-associated fibroblast-
derived microenvironmental cues and bioluminescence
was more sensitive than manual measurement in
detecting differences between various types of
microenvironmental cues
Co-inoculating DOKWT with 105 CAFs in the tongues of
NSG mice increased tumor incidence from 16.66% to
57.14% (Figure 4A). Histological sections of the tumors
formed by DOKWT 1 CAF showed typical squamous cell
carcinoma histology with invasive epithelial islands growing
in the host stroma and keratin pearl formation (Figures 4D
and 4E). The only 1 tumor formed by the DOKWT alone,
which was detected manually, was found histologically to be
surviving DOKWT cells within remnants of undissolved
matrigel (Figures 4B and 4C). When 2 different types of
fibroblasts (CAF15_13 and CAF15_23) were tested for their
stimulative support for the in vivo growth of DOKLuc, biolu-
minescence seemed to be more sensitive than the manual
FIGURE 4. (A) Carcinoma-associated fibroblasts (CAFs) increased tumor incidence of early neoplastic oral keratinocytes wild type (DOK)WT when
co-inoculated in the tongues of NSG mice. (B and C) Hematoxylin-eosin section of the tumor detected in DOKWT group presenting surviving DOK
cells (black arrows) within remnants of matrigel (yellow arrows). (D and E) Hematoxylin-eosin section of tumor formed by DOKWT 1 CAF; depicting
typical squamous cell carcinoma morphology with keratin pearls (black arrows). (F) Graphs comparing the volumes by manual measurements from
the last timepoint (week 7) of the tumors formed by 2 different strains of CAFs. (G) Comparison of total photon intensities at week 7 measured by
bioluminescence. (H) Comparing tumor area from histology after 7 weeks (*p 5 .028). [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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measurement in detecting differences in the tumor growth of
xenografts (Figures 4F and 4G), although the difference was
not statistically significant. This difference was also observed
by histological area calculations after 7 weeks, this time with
statistical significance (p 5 .028; Figure 4H).
Both bioluminescence and manual measurement
showed high correlation with histological area of the
tumors, but tumor formation was detected earlier by
bioluminescence
Bioluminescence consistently disclosed a higher number of
tumors throughout all 5 weeks of monitoring compared to
visible tumors measured manually by calipers (Figures 5A–
5D). Both the tumor volume as quantified by caliper (man-
ual) measurements and the bioluminescence signal from the
corresponding tumor at the last timepoint showed a positive
correlation with the tumor area quantified from histological
sections (considered to be the “golden standard”). A stronger
significant correlation (r 5 0.846; p < .001) was found
between the histological tumor area and bioluminescence sig-
nals than between the histological tumor area and the manual
measurement (r 5 0.739; p < .001; Figures 5E and 5F).
Development of tumors from early neoplastic oral
keratinocyte luciferase-transduced grown on poly L-
lactide-co-E-caprolactone scaffolds under different
microenvironmental cues was successfully monitored
noninvasively by bioluminescence
DOKLuc were cultured on poly(LLA-co-CL) scaffolds
at 3 different densities with or without CAFs. Total pho-
ton count from bioluminescence showed significantly
higher bioluminescence intensity of scaffolds
FIGURE 5. (A and B) Compari-
son of number of tumors
detected by bioluminescence
(BLI) and manually in the
tongue inoculations at both
densities. (C and D) Comparison
in the skin inoculations (p 5
.043; n 5 24). (E) Histological
areas correlate with biolumi-
nescence signals with a stron-
ger correlation (Spearman’s
correlation, r 5 0.847; p <
.001); than with (F) manual
measurements.
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xenotransplanted with DOKLuc 1 CAFs than of DOKLuc
alone at all densities, just above the threshold 1 week
after xenotransplantation and throughout the 12 weeks of
in vivo imaging (106: p < .001; 105: p < .001; 103: p 5
.017; Figure 6C). In the scaffolds xenotransplanted with
DOKLuc alone, no tumors were formed outside the scaf-
folds and the bioluminescence signal stayed within the
same range throughout the 12 weeks of imaging (Figure
6A). In contrast, the bioluminescence intensity of scaffolds
cocultured with CAFs increased with time (Figure 6B),
indicating an increase in tumor growth over time, and this
was confirmed by histology. After 12 weeks, histological
analysis of xenotransplants of scaffolds with DOKLuc cells
alone showed the presence of few atypical epithelial cells,
limited to the scaffold area (Figures 7A, 7B, 7F, and 7G).
Around the remnants of the scaffolds, scattered giant cells
of mouse origin were observed (Figure 7K, blue arrow).
The origin of the epithelial cells was confirmed by immu-
nostaining using an antibody against human p53, recogniz-
ing only p53 mutated human cells, DOK. In contrast, the
histology of xenografts of DOKLuc 1 CAFs scaffolds
showed squamous epithelial tumor nests (confirmed by
p53 positive staining; Figures 7C, 7D, 7I, and 7J), with
many of the islands retaining differentiation and containing
keratin pearls, growing within and outside the scaffold
area, invading the surrounding connective tissue and mus-
culature, thus displaying the characteristic hallmarks of
head and neck carcinoma. Few fibroblasts were observed
in the xenotransplants even after 12 weeks of growth in
vivo in mice (Figure 7K, black arrow). Figure 7E shows
the pronounced macroscopic differences observed during
harvesting of the scaffolds.
DISCUSSION
This study describes the development of a noninvasive,
in vivo model for testing the tumorigenic potential of var-
ious microenvironmental cues, including scaffolds
intended for use in tissue engineering. Numerous studies34
support the concept that carcinogenesis, including head
and neck cancer, is a multistep process involving a pre-
malignant phase of long-term accumulated chromosomal
alterations.35 The use of normal cells in tumor models is
time-consuming, if not irrelevant, because it is well-
known that the transformation of human cells is a long
process, involving at least 5 to 7 mutagenic events, which
are difficult to achieve in an experimental setting.20,36 For
the present model, the DOK cell line, exhibiting early
neoplastic epithelial dysplastic features was selected as a
“screening sensor.”23 To facilitate the noninvasive visual-
ization of these cells after xenotransplantation, they were
transduced with luciferase gene, successfully generating a
new cell line, DOKLuc. The in vitro growth and behav-
ioral characteristics of the transfected cells were compara-
ble to those of the parent cells. To evaluate their behavior
in vivo, both cell lines (DOKWT and DOKLuc) were xeno-
transplanted alone at low and high densities, both ortho-
topically, in the tongue, and ectopically, on the back of
NSG mice. With a single exception for the tumor size
when injected in the tongue at high density, DOKWT and
DOKLuc showed a comparable in vivo behavior as well.
FIGURE 6. (A) Bioluminescence images of a representative mouse carrying a scaffold with a low density (1 3 103) in the upper right back and high
density (1 3 106) of early neoplastic oral keratinocyte luciferase-transduced (DOKLuc) alone in the upper left back. (B) Developing tumors with bio-
luminescence imaging of mice carrying low density (upper right) and high density (lower left) of DOKLuc cocultured with (1 3 105) carcinoma-
associated fibroblasts (CAFs). (C) Total photon count from in vivo imaging using DOKLuc at different densities showed significantly higher biolumi-
nescent intensity of scaffolds xenotransplanted with DOKLuc 1 CAFs than of DOKLuc alone throughout 12 weeks of imaging (106: p < .001; 105: p <
.001; and 103: p5 .017; n5 6). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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This indicates that the DOK cell line retained a high
degree of stability after transfection, although it carried a
complex karyotype and multiple mutations, including p53
mutations. In accordance with previous oral carcinogene-
sis animal studies, the incidence and size of subcutaneous
tumors in the present study was lower than those of
tongue tumors.16 This could be related to a greater stimu-
lation of lymphangiogenesis in the tongue area16 or sim-
ply because of the fact that orthotopic models allow cells
to grow better in their original environment.
When DOKWT cells were co-inoculated with CAFs in
the tongue, the incidence of tumor formation increased by
more than 40% compared with tumors formed by DOKWT
alone. This further highlights the important role of the
microenvironmental cues in tumor initiation and early
growth, supporting previous studies.37,38 The tumor
detected by manual measurements formed by DOKWT
was proven later on, histologically, to contain mainly
remnants of matrigel, which might have given the mass
that could be measurable by the caliper, and only few
islands of nonproliferative DOK cells. This illustrates one
of the drawbacks of the manual measurements that can be
avoided by the use of other methods, such as
bioluminescence.
In this study, bioluminescence detected more than 50%
of the total number of tumors formed in the tongue by
DOKLuc from the first week; much earlier than tumor
detection with caliper measurements. In the skin tumors,
FIGURE 7. (A–D) Hematoxylin-eosin staining showing histology of early neoplastic oral keratinocyte luciferase-transduced (DOKLuc) and DOKLuc 1
carcinoma-associated fibroblasts (CAFs) xenografts respectively. (E) Dissection of a mouse after 12 weeks showing implanted scaffolds with: (1)
105 DOKLuc cells alone; (2) 105 DOKLuc cocultured with 105 CAF; and (3) empty scaffold. (F and G) Human p53 immunohistochemistry (IHC) showing
the presence of few surviving human p53 mutated transformed epithelial cells in a scaffold xenotransplanted with DOKLuc alone. (I and J) Human
p53 immunohistochemistry showing islands of atypical epithelial cells within and outside the scaffold in DOKLuc 1 CAFs xenografts (original mag-
nification 325 and 3200). Scale bar 5 1 mm and 200 lm, respectively. (H and K) Double staining for human vimentin (red cytoplasmic stain) and
human p53 (brown nuclear stain). (K) Positive vimentin stained human fibroblasts present after 12 weeks in DOKLuc 1 CAFs xenografts (black
arrow). The giant cells are negative for both human markers (blue arrow). Scale bar 100 lm (original magnification 3400). [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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6 of 7 were visible by bioluminescence from the first
week. One of the tumors was from low density inocula-
tions, which were too small for detection by manual
measurements, but it was later confirmed histologically.
The total number of tumors detected by bioluminescence
was significantly greater than manual detection (p 5
.043), and in concordance with the histological findings,
indicating higher sensitivity for early detection using the
bioluminescence method.
The measurements from the last timepoint of tumor
growth assessment period showed higher bioluminescence
signals from tumors with CAF15_23 than those with
CAF15_13; this difference was not detected by the man-
ual measurements. Histological evaluation confirmed stat-
istically bigger tumors formed by DOKLuc co-injected
with the CAF15_23, a difference that was not indicated
by the manual measurements. This brings further indica-
tions for the greater sensitivity of the bioluminescence
method compared to the manual method that might carry
subjective evaluations (eg, inflammation, tongue pull,
position of the mouse, and lesion margins).
Degradable copolymer scaffolds were used to further
optimize and validate the model for use in screening tests
for tumorigenesis of various microenvironmental cues
from biomaterials. The manual monitoring of tumors at
early stages was impossible because the tumors initially
developed within the scaffold. However, this was not an
impediment for bioluminescence. The correlation between
bioluminescence signals and the golden standard method
of histological examination was higher, confirming the
method is more sensitive than manual measurements.
Therefore, bioluminescence was further used solely to
monitor the scaffolds when developing the model.
A challenge for using the bioluminescence method
would be monitoring of bigger tumors. We monitored a
drop in intensity for a tumor developed from very high
seeding density of DOKLuc 1 CAFs xenografts (1 3
106). We interpreted that to be an underestimation of the
real bioluminescence signal from the cells because that
tumor was later found to be cystic. Cystic content or
necrosis that can occur in large or late stage tumors might
reduce the production of light because of decreased pro-
liferation or hypoxia.27,39 Therefore, we recommend inoc-
ulating fewer cells per area of scaffold in order to
circumvent these limitations and monitor tumor formation
for longer period of times, as required in carcinogenesis
studies. Although the use of such immunodeficient mod-
els greatly aids the development of “humanized” models
of cancer using biomaterials,25 it does come with the
caveat of no innate host immunity. Whereas this limita-
tion prevents the current study of role of the immune sys-
tem in tumor prevention in such models or the use of
immunotherapeutic interventions, steps have been made
to circumvent such constraints. Recent efforts have dem-
onstrated that introduction of distinct human immune
components are possible in mice xenografted with cancer
cell lines,40 suggesting that further evolution of the NSG
mice system may yet render models to study human
immune reactions in cancer.
Our model provides an abridged alternative to the years
spent in rodent models to get tumors from biomaterials
implanted solely in animals and foreign body tumorigene-
sis has several stages, with specific sequences of preneo-
plastic characteristics.12,41 The processing time is reduced
because of the ability of screening several animals simul-
taneously, which makes it cheaper compared to other
high throughput imaging methods used in the field, such
as MRI.
CONCLUSIONS
The model generated and validated in this study is a
sensitive and reliable model for monitoring microenviron-
mentally induced carcinogenesis providing early, consist-
ent surveillance of tumor development associated with
implantation of scaffolds for tissue engineering.
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